London and Berlin--European medical cannabis company Cantourage announced in a press release that it has received two British government licenses that authorize the company to import medical cannabis into the UK. The company has also received the required regulatory registration to prescribe medical cannabis products to clients via a new facility, Cantourage Clinic.
The company's subsidiary Cantourage UK, formed in January 2021, has now been awarded a WDA(H) (Wholesaler Dealer's Authorisation) license from Britain's Medicines and Healthcare products Regulatory Agency (MHRA). The license allows Cantourage UK to import and distribute medicinal products for human use. Cantourage UK was awarded the license on 10th December 2021 following inspection by the MHRA, an executive agency of the Department of Health and Social Care (DHSC).
Cantourage UK is now also in receipt of the necessary narcotics license from the Home Office to handle cannabis-based products for medicinal use, under the Misuse of Drugs Regulations 2001.